Home
RGEN
RGEN News

Latest Repligen Corporation (RGEN) News on January 19, 2025

Argus Research

4 days ago

RGEN: Raising target price to $139.00

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Zacks

4 days ago

HRMY or RGEN: Which Is the Better Value Stock Right Now?

Morningstar Research

5 days ago

Analyst Report: Repligen Corporation

3 US Stocks Including Advanced Energy Industries That May Be Priced Below Estimated Value

Simply Wall St.

10 days ago

3 US Stocks Including Advanced Energy Industries That May Be Priced Below Estimated Value

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

11 days ago

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Repligen Launches the CTech™ SoloVPE® PLUS System

GlobeNewswire

12 days ago

Repligen Launches the CTech™ SoloVPE® PLUS System

Argus Research

a month ago

RGEN: Lowering target price to $131.00

Repligen Corporation (RGEN) Fell Along with Peers

Insider Monkey

a month ago

Repligen Corporation (RGEN) Fell Along with Peers

Morningstar Research

a month ago

Analyst Report: Repligen Corporation

Argus Research

a month ago

RGEN: Raising target price to $140.00

Morningstar Research

a month ago

Analyst Report: Repligen Corporation

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

PR Newswire

a month ago

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue?

Zacks

a month ago

Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue?

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

GlobeNewswire

a month ago

Repligen Announces Publication of the Company’s 2023 Corporate Sustainability Report

Argus Research

a month ago

RGEN: Raising target price to $137.00

Several Factors Lifted Repligen Corporation (RGEN) in Q3

Insider Monkey

a month ago

Several Factors Lifted Repligen Corporation (RGEN) in Q3

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns

GlobeNewswire

a month ago

Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns

MT Newswires

a month ago

RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating

Argus Research

2 months ago

RGEN: Raising target price to $134.00

Argus Research

2 months ago

RGEN: Raising target price to $132.00

3 US Stocks Estimated To Be Trading At Discounts Up To 49.1%

Simply Wall St.

2 months ago

3 US Stocks Estimated To Be Trading At Discounts Up To 49.1%

MT Newswires

2 months ago

Repligen Insider Sold Shares Worth $3,386,439, According to a Recent SEC Filing

MT Newswires

2 months ago

Wolfe Research Initiates Repligen at Peer Perform

MT Newswires

2 months ago

UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating

Morningstar Research

2 months ago

Analyst Report: Repligen Corporation

Company News for Nov 13, 2024

Zacks

2 months ago

Company News for Nov 13, 2024

Thomson Reuters StreetEvents

2 months ago

Q3 2024 Repligen Corp Earnings Call

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

2 months ago

Repligen Corp (RGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Argus Research

2 months ago

RGEN: Raising target price to $134.00

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

Zacks

2 months ago

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

MT Newswires

2 months ago

Top Midday Gainers

Repligen Stock Soars 10% on Record Growth and Bold Moves

GuruFocus.com

2 months ago

Repligen Stock Soars 10% on Record Growth and Bold Moves

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates

Zacks

2 months ago

Repligen (RGEN) Q3 Earnings and Revenues Beat Estimates

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Repligen Q3 Adjusted Earnings, Revenue Rise; 2024 Guidance Updated

Associated Press Finance

2 months ago

Repligen: Q3 Earnings Snapshot

Repligen Reports Third Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Repligen Reports Third Quarter 2024 Financial Results

Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings

GuruFocus.com

2 months ago

Repligen Corp (RGEN) Q3 2024: Everything You Need to Know Ahead of Earnings

Argus Research

2 months ago

RGEN: Raising target price to $121.00

Repligen Corporation to Present at Upcoming Investor Conferences

GlobeNewswire

2 months ago

Repligen Corporation to Present at Upcoming Investor Conferences

Repligen to Report Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Repligen to Report Third Quarter 2024 Financial Results

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

3 months ago

Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Zacks

3 months ago

Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release

US Stocks Estimated Below Intrinsic Value In October 2024

Simply Wall St.

3 months ago

US Stocks Estimated Below Intrinsic Value In October 2024

3 investable themes, categories outside of the AI trade

Yahoo Finance Video

3 months ago

3 investable themes, categories outside of the AI trade

Argus Research

3 months ago

RGEN: Lowering target price to $116.00

Morningstar Research

3 months ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Morningstar Research

4 months ago

Analyst Report: Repligen Corporation

MT Newswires

4 months ago

Repligen Opens Training & Innovation Center

Repligen Opens Training & Innovation Center to Elevate Customer Experience

GlobeNewswire

4 months ago

Repligen Opens Training & Innovation Center to Elevate Customer Experience

MT Newswires

4 months ago

Repligen to Restate Financial Results on COVID-Related Payment Cancellation

MT Newswires

4 months ago

RBC Raises Price Target on Repligen to $205 From $190, Keeps Outperform Rating

Several Headwinds Dragged Repligen Corporation (RGEN) in Q2

Insider Monkey

4 months ago

Several Headwinds Dragged Repligen Corporation (RGEN) in Q2

Reasons for the Decline of Repligen (RGEN) in Q2

Insider Monkey

4 months ago

Reasons for the Decline of Repligen (RGEN) in Q2

Repligen Corporation (RGEN) Fell Due to CEO Transition

Insider Monkey

4 months ago

Repligen Corporation (RGEN) Fell Due to CEO Transition

Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?

Zacks

5 months ago

Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?

Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate

Simply Wall St.

5 months ago

Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate

Argus Research

5 months ago

RGEN: Lowering target price to $117.00

Repligen Corporation (RGEN) Benefitted From Drug Approval

Insider Monkey

5 months ago

Repligen Corporation (RGEN) Benefitted From Drug Approval

Repligen Corporation to Present at Wells Fargo Healthcare Conference

GlobeNewswire

5 months ago

Repligen Corporation to Present at Wells Fargo Healthcare Conference

Argus Research

5 months ago

RGEN: Lowering target price to $126.00

MT Newswires

5 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

5 months ago

Sector Update: Health Care

MT Newswires

5 months ago

Market Chatter: Maravai LifeSciences Receives Acquisition Offer From Repligen

Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?

Insider Monkey

5 months ago

Do You Believe in the Growth Prospects of Repligen Corp. (RGEN)?

MT Newswires

5 months ago

Repligen Insider Sold Shares Worth $1,139,016, According to a Recent SEC Filing

Here's Why Shares in This Hot Healthcare Stock Surged This Week

Motley Fool

6 months ago

Here's Why Shares in This Hot Healthcare Stock Surged This Week

3 US Stocks Estimated To Be Undervalued By Up To 40.1%

Simply Wall St.

6 months ago

3 US Stocks Estimated To Be Undervalued By Up To 40.1%

Repligen Second Quarter 2024 Earnings: EPS Misses Expectations

Simply Wall St.

6 months ago

Repligen Second Quarter 2024 Earnings: EPS Misses Expectations

MT Newswires

6 months ago

UBS Lowers Repligen's Price Target to $185 From $205, Buy Rating Maintained

Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates

Zacks

6 months ago

Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates

MT Newswires

6 months ago

Deutsche Bank Adjusts Repligen Price Target to $175 From $155, Maintains Buy Rating

Thomson Reuters StreetEvents

6 months ago

Q2 2024 Repligen Corp Earnings Call

Repligen (RGEN) Q2 Earnings Meet Estimates

Zacks

6 months ago

Repligen (RGEN) Q2 Earnings Meet Estimates

MT Newswires

6 months ago

Repligen Q2 Adjusted Earnings, Revenue Fall; Narrows 2024 Revenue Outlook

Associated Press Finance

6 months ago

Repligen: Q2 Earnings Snapshot

Repligen Reports Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Repligen Reports Second Quarter 2024 Financial Results

MT Newswires

6 months ago

Repligen Signs Deal to Acquire Tantti Laboratory

Should You Consider Investing in Repligen Corporation (RGEN)?

Insider Monkey

6 months ago

Should You Consider Investing in Repligen Corporation (RGEN)?

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

GlobeNewswire

6 months ago

Repligen Announces Agreement to Acquire Chromatography Innovator Tantti

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Argus Research

6 months ago

RGEN: Lowering target price to $116.00

Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate Repligen (RGEN) to Report a Decline in Earnings: What to Look Out for

Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now?

Insider Monkey

6 months ago

Repligen Corporation (RGEN): Why Are Hedge Funds Bullish On This Profitable Stock Right Now?

Exploring Three Stocks Estimated to Trade Below Intrinsic Value With Discounts Up to 31%

Simply Wall St.

6 months ago

Exploring Three Stocks Estimated to Trade Below Intrinsic Value With Discounts Up to 31%

Argus Research

6 months ago

RGEN: Rating decreased to a SELL

Repligen to Report Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Repligen to Report Second Quarter 2024 Financial Results

MT Newswires

6 months ago

Repligen Reports Attempted Cybersecurity Incident

Argus Research

6 months ago

RGEN: Raising target price to $127.00

Argus Research

7 months ago

RGEN: Lowering target price to $126.00

Unveiling Three Stocks That May Be Trading Below Their Estimated Intrinsic Value

Simply Wall St.

7 months ago

Unveiling Three Stocks That May Be Trading Below Their Estimated Intrinsic Value

Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?

Zacks

7 months ago

Repligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?

MT Newswires

7 months ago

RBC Cuts Price Target on Repligen to $190 From $221, Maintains Outperform Rating

What Is Repligen Corporation's (NASDAQ:RGEN) Share Price Doing?

Simply Wall St.

7 months ago

What Is Repligen Corporation's (NASDAQ:RGEN) Share Price Doing?

MT Newswires

7 months ago

Guggenheim Initiates Repligen With Neutral Rating

Argus Research

7 months ago

Daily – Vickers Top Buyers & Sellers for 06/17/2024

Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN)

GuruFocus.com

7 months ago

Insider Buying: CEO Anthony Hunt Acquires Shares of Repligen Corp (RGEN)

Director Nicolas Barthelemy Acquires 1,200 Shares of Repligen Corp (RGEN)

GuruFocus.com

7 months ago

Director Nicolas Barthelemy Acquires 1,200 Shares of Repligen Corp (RGEN)

Share on Social Networks: